unani treatment of Kathra al-Bawl (Overactive Bladder) with Jawarish Kundur and Oxybutyni
Phase 2
- Conditions
- Health Condition 1: N30-N39- Other diseases of the urinary system
- Registration Number
- CTRI/2023/03/050407
- Lead Sponsor
- Central Council for research in Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
History of all or any of the following symptoms for more than six months
1. Urgency of urine
2. Incontinence
3. Frequency
4. Nocturia
Exclusion Criteria
The following patients will be excluded from the study
1.Patients with history of Bladder calculus
2.Patients with Urinary tract infections
3.Known case of Benign Prostrate Hypertrophy
4.Known case of Uterine prolapse
•Patients with Rectocele/cystocele
•Patients with Cystitis
•Pregnant and lactating females
•Known case of Neoplasm
•Known case of with Hepatic/Cardiac diseases
•Known case of Multiple sclerosis and Spinal cord injury.
•Medications (anticholinergic, antidepressant, psychotropic, or alpha-blocker)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Haematological and biochemical assessment for safety assessmentTimepoint: At baseline and after 6 weeks
- Secondary Outcome Measures
Name Time Method Improvement in OABSS, SF36, CES-D scoreTimepoint: 2 weeks